Global contract development and manufacturing organization Recipharm has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.
The agreement was announced following the successful quality audit and will see Recipharm aseptically pack single-use vaccines used to treat a severe infectious disease that affects both young children and infants.
